Table 4 Bland-Altman analysis results for differences between voxelwise tumour-to-blood ratio values
From: Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
Lesion # | Mean ± SD (95 % CI) | LLA, ULA |
|---|---|---|
1 | −0.21 ± 0.12 (−0.45 to 0.04) | −0.45, 0.04 |
2 | 0.11 ± 0.10 (0.10 to 0.12) | −0.09, 0.31 |
3 | −0.04 ± 0.09 (−0.05 to −0.03) | −0.21, 0.13 |
4 | −0.01 ± 0.13 (−0.03 to 0.00) | −0.26, 0.23 |
5 | 0.14 ± .19 (0.11 to 0.17) | −0.23, 0.51 |
6 | 0.04 ± 0.09 (0.03 to 0.05) | −0.13, 0.21 |
7 | 0.04 ± 0.07 (0.03 to 0.05) | −0.11, 0.18 |
8 | 0.04 ± 0.04 (0.03 to 0.05) | −0.04, 0.13 |
9 | −0.03 ± 0.09 (−0.03 to −0.02) | −0.20, 0.15 |
10 | −0.01 ± 0.06 (−0.02 to −0.01) | −0.12, 0.09 |
11 | 0.10 ± 0.05 (0.09 to 0.11) | 0.00, 0.20 |
12 | 0.05 ± 0.09 (0.04 to 0.06) | −0.13, 0.24 |
13 | 0.01 ± 0.11 (0.00 to 0.02) | −0.20, 0.22 |
14 | 0.01 ± 0.10 (−0.01 to 0.02) | −0.19, 0.20 |
15 | 0.09 ± .07 (0.07 to 0.11) | −0.05, 0.22 |
16 | −0.13 ± 0.07 (−0.14 to −0.12) | −0.28, 0.01 |
17 | 0.07 ± 0.07 (0.06 to 0.08) | −0.06, 0.20 |
18 | 0.01 ± 0.07 (0.00 to 0.02) | −0.12, 0.14 |
19 | 0.08 ± 0.07 (0.07 to 0.10) | −0.05, 0.22 |
Pooled data | 0.01 ± 0.12 (0.01 to 0.02) | −0.22, 0.24 |